Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP960998.RAQvmWHZd6NezvOhzu1etWFDRtBbXZqk2RLH60nJL99yE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP960998.RAQvmWHZd6NezvOhzu1etWFDRtBbXZqk2RLH60nJL99yE130_assertion type Assertion NP960998.RAQvmWHZd6NezvOhzu1etWFDRtBbXZqk2RLH60nJL99yE130_head.
- NP960998.RAQvmWHZd6NezvOhzu1etWFDRtBbXZqk2RLH60nJL99yE130_assertion description "[High expression of the p53-antagonist MDM2 in human retinoblastomas may compromise p53 tumor surveillance so that TP53 mutations are not selected for in retinoblastoma tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP960998.RAQvmWHZd6NezvOhzu1etWFDRtBbXZqk2RLH60nJL99yE130_provenance.
- NP960998.RAQvmWHZd6NezvOhzu1etWFDRtBbXZqk2RLH60nJL99yE130_assertion evidence source_evidence_literature NP960998.RAQvmWHZd6NezvOhzu1etWFDRtBbXZqk2RLH60nJL99yE130_provenance.
- NP960998.RAQvmWHZd6NezvOhzu1etWFDRtBbXZqk2RLH60nJL99yE130_assertion SIO_000772 22336108 NP960998.RAQvmWHZd6NezvOhzu1etWFDRtBbXZqk2RLH60nJL99yE130_provenance.
- NP960998.RAQvmWHZd6NezvOhzu1etWFDRtBbXZqk2RLH60nJL99yE130_assertion wasDerivedFrom befree-2016 NP960998.RAQvmWHZd6NezvOhzu1etWFDRtBbXZqk2RLH60nJL99yE130_provenance.
- NP960998.RAQvmWHZd6NezvOhzu1etWFDRtBbXZqk2RLH60nJL99yE130_assertion wasGeneratedBy ECO_0000203 NP960998.RAQvmWHZd6NezvOhzu1etWFDRtBbXZqk2RLH60nJL99yE130_provenance.